Literature DB >> 1008543

Antibiotic penetrance of ascitic fluid in dogs.

D N Gerding, J P Kromhout, J J Sullivan, W H Hall.   

Abstract

Antibiotic concentrations in ascitic fluid after parenteral therapy may be important in the treatment of peritonitis. We have created ascites in dogs by partial ligation of the inferior vena cava. Ascitic fluid volume was measured at the time each antibiotic was administered. Nine antibiotics were studied in the same three dogs. Antibiotic concentration in ascitic fluid was found to vary inversely with ascites volume. Percentage of penetration (ratio of ascites peak to serum peak x100) ranged from 5.8 to 65% among the drugs studied. Only metronidazole showed a statistically significant higher percentage of penetration than other antimicrobials. Concentrations in ascitic fluid after single doses of cephalothin (15 mg/kg) and the aminoglycosides (2 mg/kg, gentamicin and tobramycin; 7.5 mg/kg, amikacin and kanamycin) did not exceed the minimum inhibitory concentration of many gram-negative rods and may justify the use of higher than usual initial parenteral doses, or possibly initial intraperitoneal administration in seriously ill patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008543      PMCID: PMC429847          DOI: 10.1128/AAC.10.5.850

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  PERITONEAL TRANSPORT OF ANTIBIOTICS IN MAN.

Authors:  L SHEAR; J H SHINABERGER; K G BARRY
Journal:  N Engl J Med       Date:  1965-04-01       Impact factor: 91.245

2.  Observations on the origin of ascites from experimental hepatic congestion.

Authors:  R E HYATT; G H LAWRENCE; J R SMITH
Journal:  J Lab Clin Med       Date:  1955-02

3.  The mechanism of ascites, a physiologic appraisal.

Authors:  R E HYATT; J R SMITH
Journal:  Am J Med       Date:  1954-03       Impact factor: 4.965

4.  Spontaneous peritonitis in cirrhotic ascites. A decade of experience.

Authors:  N Curry; R W McCallum; P H Guth
Journal:  Am J Dig Dis       Date:  1974-08

5.  Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin.

Authors:  S Oppenheimer; M Turek
Journal:  Am J Med Sci       Date:  1968-11       Impact factor: 2.378

6.  Microbiological agar diffusion assay for metronidazole concentrations in serum.

Authors:  M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

7.  The use of gentamicin in peritoneal dialysis. I. Pharmacologic results.

Authors:  T Smithivas; P J Hyams; R Matalon; M S Simberkoff; J J Rahal
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

9.  Metronidazole bioassay.

Authors:  W T Speck; A B Stein; H S Rosenkranz
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

10.  Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  Br Med J       Date:  1974-09-28
View more
  7 in total

Review 1.  The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy.

Authors:  R Wise
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

2.  Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis.

Authors:  G D Richey; C J Schleupner
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

3.  Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.

Authors:  C Silvain; S Bouquet; J P Breux; B Becq-Giraudon; M Beauchant
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.

Authors:  D N Gerding; L R Peterson; D C Legler; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

5.  Disposition of cefoxitin in patients with ascites.

Authors:  M J Garcia; A Dominguez-Gil; F D Perez; F P Rodriguez; F D Moronta
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Comparative penetration of various cephalosporins into inflammatory exudate.

Authors:  I C Guerrero; R R MacGregor
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

7.  Penetration and clearance of cefoperazone and moxalactam in pleural fluid.

Authors:  H Yamada; T Iwanaga; H Nakanishi; M Yamaguchi; K Iida
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.